Month: September 2022

Can myeloma be monitored using only blood testing? In this week’s #AskDrDurie multiple myeloma expert Dr. Brian G.M. Durie discusses if blood testing can accurately monitor the disease. The BOTTOM LINE: While bone marrow biopsy is still needed at initial…

Multiple myeloma: Colin Powell treated for blood cancer prior to his death Despite getting vaccinated against COVID-19, Colin Powell remained vulnerable to the virus because of his advanced age and history of cancer.

Testing for Newly Diagnosed Plasma Cell Myeloma To assist in the care of patients with newly diagnosed plasma cell myeloma, Mayo Medical Laboratories offers two tests that can help with plasma cell clonality determination and proliferation rate as well as…

Optimal treatment sequencing in multiple myeloma Guy Pratt, MD, FRCP, FRCPath, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK, discusses treatment sequencing in multiple myeloma, underlining the importance of selecting the best available treatment in first line. Multiple lines of…

Pursue 18 E (Live): Plasma Cell Neoplasms : The ABC of Myeloma Pursue 18 E (Live): Hematology – Malignant Lymphoid & Plasmacytic Diseases Plasma Cell Neoplasms: General Considerations. Classification . The ABC of Myeloma Lecture conducted by: Dr Manasi Mundada…

Understanding Treatment Planning in Multiple Myeloma Rafael Fonseca, MD; Gareth Morgan, MD, PhD; and Thomas G. Martin, MD, highlight the importance of treatment planning at all stages in the continuum of multiple myeloma.

Causes of Multiple Myeloma | Dr. Sainath Bhethanabhotla | CARE Hospitals, Banjara Hills What are the risk factors and causes for multiple myeloma and the age factor who are at risk of Multiple Myeloma discussed by Dr. Sainath Bhethanabhotla from…

Multiple Myeloma: Past, Present and Future Presented By: Kareem Azab, PhD Speaker Biography: Prof. Azab earned a Pharmacy degree (2000), MSc in Medicinal Chemistry (2003) and a Ph.D. in Pharmaceutical Sciences (2007) from The Hebrew University of Jerusalem, and completed…

CAR-T, bispecifics and MRD: how is treatment for multiple myeloma evolving? Nikhil Munshi, MD, Dana-Farber Cancer Institute, Boston, MA, gives his thoughts on how the treatment of multiple myeloma could evolve – including the continued use of CAR-Ts, the use…

Oral Medicine | Multiple Myeloma | INBDE In this video, we discuss multiple myeloma, the Bence-Jones protein, and oral manifestations of this cancer. Thanks for watching! Support me on Patreon! ➤ https://www.patreon.com/mentaldental ➤ Reward perks include access to the slides…